ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNTX vs EXEL // GROSS PROFIT MARGIN

BioNTech SE (NASDAQ) VS. Exelixis Inc. (NASDAQ) • 15-METRIC TALLY: BNTX 3 — EXEL 9
■ METRIC PARITY
gross-margins
—
gross-margins
96.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNTX VS. EXEL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNTX EXEL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 96.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 9.90% 35.10% -25.20 EXEL /roic <GO>
EV/EBITDA & P/E Valuation 21.0x 18.4x +2.60 EXEL /valuation <GO>
Free Cash Flow Yield 2.21% 5.34% -3.13 EXEL /fcf-yield <GO>
Operating Margin 13.90% 37.60% -23.70 EXEL /operating-margins <GO>
Net Profit Margin 10.90% 33.70% -22.80 EXEL /net-margins <GO>
Revenue Growth (YoY) 14.30% 7.00% +7.30 BNTX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.74 16.64 -12.90 EXEL /balance-sheet <GO>
Piotroski F-Score Quality 8/9 9/9 -1.00 EXEL /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.4 63.3 -19.90 EXEL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.02 0.96 +0.06 BNTX /macro-sensitivity <GO>
Forward P/E Multiple 27.6x 19.5x +8.10 EXEL /forward-pe <GO>
Enterprise Scale & Market Cap $22.39B $16.40B $5.99B BNTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNTX REV EXEL REV BNTX GROSS % EXEL GROSS % BNTX FCF EXEL FCF
FY 2025 — $2.32B — 96.4% — $875.8M
FY 2024 — $2.17B — 96.5% — $671.5M
FY 2023 — $1.83B — — — $251.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNTX // BETA 1.02
EXEL // BETA 0.96